Overview of the Pharmacological Management of Osteoporosis in Postmenopausal Women
N. Sherly Shulamite *
Department of Clinical Pharmacy, SIMS College of Pharmacy, Guntur, Andhra Pradesh, 522001, India.
B. Pragna Malavika
Department of Pharmacy, Annamalai University, Chidambaram, Tamilnadu, 608002, India.
P. Aravinda Swami
Department of Pharmacy, Annamalai University, Chidambaram, Tamilnadu, 608002, India.
*Author to whom correspondence should be addressed.
Abstract
Aim: The aim of the study is to assess the Pharmacological management of osteoporosis in postmenopausal women.
Objective: The purpose of this study is to evaluate the treatment of osteoporosis in postmenopausal women.
Methodology: This is an observational prospective study, carried out in a tertiary care hospital.
Results: A total of 300 postmenopausal women were enrolled in the study. The mean ± standard deviation, of the age of postmenopausal women included in this study was 55.5 ± 5.0 years. 68.1% were prescribed with the combinational therapy of Teriparatide+Bisphosphonates. 39.2% of subjects were using acetaminophen for pain.
Conclusion: Antiresorptive drugs (hormonal therapy, bisphosphonates, and denosumab) and, the anabolic agents (teriparatide) are commonly prescribed, in this study it is obvious that Sequential Therapy is highly prevailing in the clinical practice, with 68.1%.
Keywords: Osteoporosis, postmenopausal women, antiresorptive drugs